Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adults between 19-year-old and 40-year-old during the screening day~* BMI between 19 kg/m² and 30 kg/m² during the screening day~* Be able to give an informed consent form after understanding for reasonable explanation of clinical trial's purpose, contents and characteristics of clinical drugs~* Wiling to participate whole clinical trial periods~Exclusion Criteria:~* Person who is able to clinically affect to the study through ECG result during the screening day~* Has critical issue for Torsade de points from heart failure, hypopotassemia, arrhythmia etc., or family history for long QT syndrome, sudden cardiac death.~* Was suffered, or is suffering from like liver, kidney, digestive system, circulatory system, respiratory system, endocrine system(except diabetes), musculoskeletal, neuropsychiatry, or hemato-oncology etc., which is able to effect on clinical study~* Has allergy which is required the treatment or hypersensitive from drugs such as aspirin, anti-biotics, anti-depressants, etc.~* Was administered any drug of other clinical study within 90 days from the randomization day.~* Donated whole blood within 60days or apheresis within 30 days from the randomization day.~* Took any medicine or oriental medicine within 2 weeks, or general pharmaceuticals within 7 days from the randomization day. (For general pharmaceuticals circumstances, PI could decide whether he/she is suitable for the study)~* No intention to take contraceptive which is approved as clinical way, or is planning on giving their sperm or egg during the whole clinical trial.~* Average alcohol consumption per week: \>140g~* Average smoking per day: \>20~* Average grapefruit juice consumption per day: \>4 glasses~* systolic blood pressure \<100 mmHg or \>150 mmHg, or diastolic pressure \<70 mmHg or \>100mmHg~* Over 2 times from the maximum reference interval of AST and ALT levels in the blood.~* eGFR by MDRD from creatinine in the blood is less than 30 mL/min.~* doesn't show negative reaction from HIV Test, B hepatitis test, or C hepatitis test~* For woman, doesn't show negative reaction from pregnancy test~* PI decides the person is not suitable to participate the clinical study with other reasons.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Celecoxib, Moxifloxacin, Water in order (Type: EXPERIMENTAL): 1. Intervention Celecoxib: Celecoxib 400 mg capsule and water 150ml by mouth, daily for 6days~   Wash-out period (3\~6 days)~2. Intervention Moxifloxacin: Moxifloxacin 400 mg tablet and water 150ml by mouth, once for one day~   Wash-out period (3\~6 days)~3. Intervention Pure water: Water 150ml by mouth without any drug, once for one day
- Celecoxib, Water, Moxifloxacin in order (Type: EXPERIMENTAL): 1. Intervention Celecoxib: Celecoxib 400 mg capsule and water 150ml by mouth, daily for 6days~   Wash-out period (3\~6 days)~2. Intervention Pure water: Water 150ml by mouth without any drug, once for one day~   Wash-out period (3\~6 days)~3. Intervention Moxifloxacin: Moxifloxacin 400 mg tablet and water 150ml by mouth, once for one day
- Moxifloxacin, Water, Celecoxib in order (Type: EXPERIMENTAL): 1. Intervention Moxifloxacin: Moxifloxacin 400 mg tablet and water 150ml by mouth, once for one day~   Wash-out period (3\~6 days)~2. Intervention Pure water: Water 150ml by mouth without any drug, once for one day~   Wash-out period (3\~6 days)~3. Intervention Celecoxib: Celecoxib 400 mg capsule and water 150ml by mouth, daily for 6days
- Water, Moxifloxacin, Celecoxib in order (Type: EXPERIMENTAL): 1. Intervention Pure water: Water 150ml by mouth without any drug, once for one day~   Wash-out period (3\~6 days)~2. Intervention Moxifloxacin: Moxifloxacin 400 mg tablet and water 150ml by mouth, once for one day~   Wash-out period (3\~6 days)~3. Intervention Celecoxib: Celecoxib 400 mg capsule and water 150ml by mouth, daily for 6days

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete